New hope for hard-to-treat pancreatic cancer?
Disease control
Not yet recruiting
This early-phase trial tests two drugs (cosibelimab and balixafortide) in 24 people with metastatic pancreatic cancer that worsened after standard chemotherapy. The goal is to find the safest dose and see if the combination can help control the disease. Participants must be 18 or…
Phase: PHASE1 • Sponsor: Arsen Osipov • Aim: Disease control
Last updated May 04, 2026 02:51 UTC